340B HEALTH for 340B HEALTH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT RECKLAUS New | — |
| TED SLAFSKY New | — |
| JAIMIE VICKERY New | — |
| WILLIAM VON OEHSEN New | — |
Pharmacy PHA
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT RECKLAUS New | — |
| TED SLAFSKY New | — |
| JAIMIE VICKERY New | — |
| WILLIAM VON OEHSEN New | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| HOLLAND & KNIGHT | Washington, DC, US |
| MCALLISTER & QUINN | Washington, DC, US |
| POWERS PYLES SUTTER & VERILLE | Washington, DC, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.